The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CNH INDL N V | SHS | N20944109 | 3,716,979,627 | 366,927,900 | SH | DFND | 1 | 366,927,900 | 0 | 0 | |
| ERMENEGILDO ZEGNA N V | ORD SHS | N30577105 | 29,600,000 | 2,500,000 | SH | DFND | 1 | 2,500,000 | 0 | 0 | |
| FERRARI N V | COM | N3167Y103 | 18,146,035,294 | 44,435,280 | SH | DFND | 1 | 44,435,280 | 0 | 0 | |
| MASIMO CORP | COM | 574795100 | 42,202,242 | 335,098 | SH | DFND | 1,2 | 335,098 | 0 | 0 | |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | 41,439,957 | 4,215,662 | SH | DFND | 1 | 4,215,662 | 0 | 0 | |
| STELLANTIS N.V | SHS | N82405106 | 8,920,790,326 | 449,410,092 | SH | DFND | 1 | 449,410,092 | 0 | 0 | |